AxoGen is a human tissue company based in Alachua, Florida making products to remedy peripheral nerve damage. In 2013 the company raised $18 million in its Initial Public Offering (IPO). AxoGen uses a cell graft technology AVANCE to mimic a human nerve. The company reports recovery in 87 percent of patients with peripheral nerve injuries. AxoGen is part of the Sid Martin Biotechnology Incubator.
Highest paying job titles at AxoGen include Area Sales Manager, Regional Sales Director, and Regional Business Manager